Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Total Liabilities 2011-2025 | ZTS

Zoetis total liabilities from 2011 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Zoetis total liabilities for the quarter ending March 31, 2025 were $9.443B, a 1.58% increase year-over-year.
  • Zoetis total liabilities for 2024 were $9.467B, a 1.85% increase from 2023.
  • Zoetis total liabilities for 2023 were $9.295B, a 11.66% decline from 2022.
  • Zoetis total liabilities for 2022 were $10.522B, a 12.46% increase from 2021.
  
Zoetis Annual Total Liabilities
(Millions of US $)
2024 $9,467
2023 $9,295
2022 $10,522
2021 $9,356
2020 $9,836
2019 $8,837
2018 $8,592
2017 $6,800
2016 $6,150
2015 $6,822
2014 $5,251
2013 $5,596
2012 $2,221
2011 $1,975
2010 $0
Zoetis Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $9,443
2024-12-31 $9,467
2024-09-30 $9,123
2024-06-30 $9,205
2024-03-31 $9,296
2023-12-31 $9,295
2023-09-30 $9,032
2023-06-30 $9,128
2023-03-31 $9,263
2022-12-31 $10,522
2022-09-30 $9,012
2022-06-30 $9,190
2022-03-31 $9,202
2021-12-31 $9,356
2021-09-30 $9,024
2021-06-30 $9,717
2021-03-31 $9,704
2020-12-31 $9,836
2020-09-30 $10,118
2020-06-30 $10,082
2020-03-31 $8,775
2019-12-31 $8,837
2019-09-30 $8,594
2019-06-30 $8,575
2019-03-31 $8,566
2018-12-31 $8,592
2018-09-30 $8,341
2018-06-30 $6,621
2018-03-31 $6,715
2017-12-31 $6,800
2017-09-30 $7,269
2017-06-30 $6,056
2017-03-31 $6,014
2016-12-31 $6,150
2016-09-30 $6,117
2016-06-30 $6,147
2016-03-31 $6,266
2015-12-31 $6,822
2015-09-30 $5,432
2015-06-30 $5,396
2015-03-31 $5,125
2014-12-31 $5,251
2014-09-30 $5,138
2014-06-30 $5,239
2014-03-31 $5,304
2013-12-31 $5,596
2013-09-30 $5,393
2013-06-30 $5,438
2013-03-31 $5,418
2012-12-31 $2,221
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $1,975
2010-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $65.610B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $77.504B 29.07
Daiichi Sankyo, - (DSNKY) Japan $46.052B 23.60
Takeda Pharmaceutical (TAK) Japan $45.947B 9.14
BeOne Medicines - (ONC) Cayman Islands $31.996B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.212B 0.00
Summit Therapeutics (SMMT) United States $19.562B 0.00
Merck (MKKGY) Germany $16.608B 12.17
Shionogi (SGIOY) Japan $14.377B 14.40
United Therapeutics (UTHR) United States $13.222B 11.70
Neurocrine Biosciences (NBIX) United States $13.047B 44.69
Orion OYJ (ORINY) Finland $10.973B 26.45
IPSEN (IPSEY) France $10.477B 0.00
Corcept Therapeutics (CORT) United States $7.436B 60.45
Madrigal Pharmaceuticals (MDGL) United States $7.348B 0.00
Stevanato Group S.p.A (STVN) Italy $7.320B 44.76
Grifols, S.A (GRFS) Spain $6.876B 0.00
Ionis Pharmaceuticals (IONS) United States $6.613B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.383B 0.00
Procaps Group, S.A (PROCF) Luxembourg $3.202B 0.00
Hypermarcas (HYPMY) Brazil $3.004B 19.76
Crinetics Pharmaceuticals (CRNX) United States $2.898B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.563B 8.98
NewAmsterdam Pharma (NAMS) Netherlands $2.533B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.479B 13.41
Centessa Pharmaceuticals (CNTA) United Kingdom $2.145B 0.00
Ocular Therapeutix (OCUL) United States $1.834B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.783B 0.00
ARS Pharmaceuticals (SPRY) United States $1.753B 0.00
Endo (NDOI) United States $1.656B 0.00
Harrow (HROW) United States $1.360B 0.00
Guardian Pharmacy Services (GRDN) United States $1.322B 0.00
Evotec AG (EVO) Germany $1.310B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.165B 23.30
Enliven Therapeutics (ELVN) United States $1.073B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.062B 0.00
Ardelyx (ARDX) United States $1.058B 0.00
Dyne Therapeutics (DYN) United States $1.042B 0.00
Akebia Therapeutics (AKBA) United States $1.009B 0.00
Collegium Pharmaceutical (COLL) United States $0.993B 5.36
Verve Therapeutics (VERV) United States $0.974B 0.00
ProKidney (PROK) United States $0.942B 0.00
Cronos Group (CRON) Canada $0.806B 0.00
Xeris Biopharma Holdings (XERS) United States $0.804B 0.00
KalVista Pharmaceuticals (KALV) United States $0.777B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.732B 0.00
Xencor (XNCR) United States $0.648B 0.00
Zevra Therapeutics (ZVRA) United States $0.641B 0.00
Relay Therapeutics (RLAY) United States $0.622B 0.00
Organogenesis (ORGO) United States $0.578B 0.00
Elite Pharmaceuticals (ELTP) United States $0.569B 0.00
Theravance Biopharma (TBPH) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.564B 12.26
Bioventus (BVS) United States $0.518B 13.12
Oruka Therapeutics (ORKA) United States $0.516B 0.00
Siga Technologies (SIGA) United States $0.489B 10.22
Tourmaline Bio (TRML) United States $0.468B 0.00
Aquestive Therapeutics (AQST) United States $0.420B 0.00
Savara (SVRA) United States $0.396B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.350B 9.46
Tonix Pharmaceuticals Holding (TNXP) United States $0.332B 0.00
Altimmune (ALT) United States $0.328B 0.00
Aldeyra Therapeutics (ALDX) United States $0.323B 0.00
Nektar Therapeutics (NKTR) United States $0.308B 0.00
AleAnna (ANNA) United States $0.300B 0.00
Heron Therapeutics (HRTX) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 25.08
OmniAb (OABI) United States $0.242B 0.00
Nanobiotix S.A (NBTX) France $0.241B 0.00
Esperion Therapeutics (ESPR) United States $0.228B 0.00
MediWound (MDWD) Israel $0.217B 0.00
Larimar Therapeutics (LRMR) United States $0.209B 0.00
4D Molecular Therapeutics (FDMT) United States $0.196B 0.00
China SXT Pharmaceuticals (SXTC) China $0.188B 0.00
Aclaris Therapeutics (ACRS) United States $0.178B 0.00
Galectin Therapeutics (GALT) United States $0.173B 0.00
Journey Medical (DERM) United States $0.168B 0.00
Profound Medical (PROF) Canada $0.167B 0.00
Liminatus Pharma (LIMN) United States $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.141B 0.00
Inhibikase Therapeutics (IKT) United States $0.140B 0.00
Avita Medical (RCEL) United States $0.138B 0.00
Protara Therapeutics (TARA) United States $0.132B 0.00
Lexeo Therapeutics (LXEO) United States $0.131B 0.00
Korro Bio (KRRO) United States $0.125B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.124B 0.00
Cassava Sciences (SAVA) United States $0.111B 0.00
Champions Oncology (CSBR) United States $0.111B 18.25
Innate Pharma SA (IPHYF) France $0.110B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.105B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
VAXART, INC (VXRT) United States $0.097B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
Nutriband (NTRB) United States $0.092B 0.00
Fractyl Health (GUTS) United States $0.088B 0.00
Wellgistics Health (WGRX) United States $0.085B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Metagenomi (MGX) United States $0.081B 0.00
Context Therapeutics (CNTX) United States $0.078B 0.00
Dominari Holdings (DOMH) United States $0.076B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Rafael Holdings (RFL) United States $0.074B 0.00
Avalo Therapeutics (AVTX) United States $0.073B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.071B 0.00
Pyxis Oncology (PYXS) United States $0.070B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.067B 0.00
Telomir Pharmaceuticals (TELO) United States $0.066B 0.00
Inotiv (NOTV) United States $0.059B 0.00
Jupiter Neurosciences (JUNS) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.057B 0.00
Klotho Neurosciences (KLTO) United States $0.055B 0.00
ElectroCore (ECOR) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.89
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Gain Therapeutics (GANX) United States $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Scienture Holdings (SCNX) United States $0.028B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Incannex Healthcare (IXHL) Australia $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Plus Therapeutics (PSTV) United States $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.018B 0.00
DURECT (DRRX) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
BioVie (BIVI) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.37
TherapeuticsMD (TXMD) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.12
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00